Pursuing Value-creating Partnerships
At Inhibikase Therapeutics, we actively seek to collaborate with pharmaceutical and biotechnology partners based on a shared, strategic focus to create innovative new kinase inhibitor drugs that treat diseases of the brain safely and effectively.
For more information, please contact:
Milton H. Werner, Ph.D.
President & CEO
917 494 0831 (m)
Forging Lasting Partnerships
We are open to forging new and lasting partnerships with those who share our goal of developing novel therapies for patients suffering from neurodegenerative diseases.